Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?-Reference-Cited by-同舟云学术

Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?

Published:2019-04 Issue:4 Volume:21 Page:749-760
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Green Charlotte J.¹^ORCID,Marjot Thomas¹,Tomlinson Jeremy W.¹²,Hodson Leanne¹²^ORCID

Affiliation:

1. Oxford Centre for Diabetes, Endocrinology and MetabolismChurchill Hospital Oxford UK

2. Oxford NIHR Biomedical Research CentreChurchill Hospital Oxford UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13592

Reference108 articles.

1. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

2. From NAFLD in clinical practice to answers from guidelines

3. A current update on the rule of alternative and complementary medicine in the treatment of liver diseases;Guan YS;Evid Based Complement Alternat Med,2013

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

5. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of PLA2G4A attenuated valproic acid- induced lysosomal membrane permeabilization and restored impaired autophagic flux: Implications for hepatotoxicity;Biochemical Pharmacology;2024-09

2. Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b Pathway;2024-04-19

3. Metformin Inefficiency to Lower Lipids in Vitamin B12 Deficient HepG2 Cells Is Alleviated via Adiponectin-AMPK Axis;Nutrients;2023-12-08

4. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD;iScience;2023-12

5. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS^−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis;NMR in Biomedicine;2023-04-11